D.E. Shaw & Co’s Celgene Corp CELG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-374,300
| Closed | -$37.2M | – | 4328 |
|
|
2019
Q3 | $37.2M | Hold |
374,300
| – | – | 0.05% | 492 |
|
|
2019
Q2 | $34.6M | Sell |
374,300
-533,700
| -59% | -$50.7M | 0.04% | 502 |
|
|
2019
Q1 | $85.7M | Sell |
908,000
-34,700
| -4% | -$3.03M | 0.11% | 218 |
|
|
2018
Q4 | $60.4M | Buy |
942,700
+393,500
| +72% | +$29M | 0.08% | 288 |
|
|
2018
Q3 | $49.1M | Buy |
549,200
+429,000
| +357% | +$37.9M | 0.06% | 408 |
|
|
2018
Q2 | $9.55M | Buy |
120,200
+69,400
| +137% | +$5.76M | 0.01% | 1103 |
|
|
2018
Q1 | $4.53M | Sell |
50,800
-80,700
| -61% | -$7.75M | 0.01% | 1474 |
|
|
2017
Q4 | $13.7M | Sell |
131,500
-280,600
| -68% | -$31.7M | 0.02% | 850 |
|
|
2017
Q3 | $60.1M | Buy |
412,100
+330,800
| +407% | +$45.1M | 0.09% | 263 |
|
|
2017
Q2 | $10.6M | Sell |
81,300
-168,700
| -67% | -$20.7M | 0.02% | 876 |
|
|
2017
Q1 | $31.1M | Sell |
250,000
-94,700
| -27% | -$11.3M | 0.05% | 408 |
|
|
2016
Q4 | $39.9M | Buy |
344,700
+99,300
| +40% | +$11.1M | 0.07% | 373 |
|
|
2016
Q3 | $25.7M | Sell |
245,400
-17,600
| -7% | -$1.9M | 0.05% | 492 |
|
|
2016
Q2 | $25.9M | Sell |
263,000
-138,800
| -35% | -$14.4M | 0.05% | 459 |
|
|
2016
Q1 | $40.2M | Buy |
401,800
+4,400
| +1% | +$453K | 0.07% | 326 |
|
|
2015
Q4 | $47.6M | Sell |
397,400
-20,900
| -5% | -$2.42M | 0.07% | 331 |
|
|
2015
Q3 | $45.2M | Buy |
418,300
+120,900
| +41% | +$15M | 0.07% | 343 |
|
|
2015
Q2 | $34.4M | Sell |
297,400
-75,600
| -20% | -$8.64M | 0.05% | 432 |
|
|
2015
Q1 | $43M | Sell |
373,000
-187,700
| -33% | -$22.4M | 0.07% | 349 |
|
|
2014
Q4 | $62.7M | Buy |
560,700
+8,700
| +2% | +$918K | 0.08% | 290 |
|
|
2014
Q3 | $52.3M | Sell |
552,000
-22,200
| -4% | -$2M | 0.07% | 335 |
|
|
2014
Q2 | $49.3M | Buy |
574,200
+318,800
| +125% | +$24.2M | 0.07% | 333 |
|
|
2014
Q1 | $17.8M | Buy |
255,400
+2,400
| +0.9% | +$190K | 0.03% | 709 |
|
|
2013
Q4 | $21.4M | Sell |
253,000
-59,800
| -19% | -$4.73M | 0.03% | 646 |
|
|
2013
Q3 | $24.1M | Buy |
312,800
+161,600
| +107% | +$11.3M | 0.04% | 506 |
|
|
2013
Q2 | $8.84M | Buy |
+151,200
| New | +$9.1M | 0.02% | 949 |
|
Other funds holding CELG
FP
HCM
PCMC
WCG
D.E. Shaw & Co's CELG Position: Q4 2019 in Review
D.E. Shaw & Co sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 4,627,564 shares — an estimated $460M sold.
D.E. Shaw & Co first reported a position in CELG in Q2 2013 and held it in 26 quarters. The position peaked at $693M in Q1 2019. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.
- D.E. Shaw & Co reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
- D.E. Shaw & Co sold 4,627,564 Celgene Corp shares in Q4 2019, an estimated $460M.
- D.E. Shaw & Co first reported a position in Celgene Corp in Q2 2013 and held it in 26 quarters.
- D.E. Shaw & Co's Celgene Corp position peaked at $693M in Q1 2019.
- 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.
Based on D.E. Shaw & Co's 13F filing for Q4 2019, filed 14 Feb 2020.